Immuno-metabolic dysregulation in female genital tuberculosis: Multi-omics insights into infertility mechanisms and therapeutic targets

ElsevierVolume 173, February 2026, 104833Journal of Reproductive ImmunologyAuthor links open overlay panel, , , Highlights•

FGTB disrupts STAT3/VEGF→implantation via endometrial granuloma formation.

Taurine↓ + TLR8 SNP predict IVF failure in latent FGTB.

DHEA rescues oocytes; intrauterine VEGF↑ implantation.

TB-FertiScore + CRISPR-POC enable risk-adapted ART in TB-endemic zones.

Abstract

Female genital tuberculosis (FGTB) is a major cause of infertility in regions where it is common, causing permanent damage to the reproductive tract. It mainly causes fibrosis and blockage of the fallopian tubes, directly hindering gamete movement. Meanwhile, FGTB leads to a decline in ovarian reserve and function by disrupting folliculogenesis in the ovaries, resulting in decreased levels of anti-Müllerian hormone (AMH). Mycobacterium tuberculosis also affects endometrial receptivity by inhibiting the STAT3/VEGF pathway and the imbalance of Th1/Th2 immune responses. This review explains these mechanisms and offers a multi-omics approach for early detection, identifying taurine deficiency in endometrial fluid and the TLR8 rs3764880 polymorphism as potential predictive markers. Importantly, we point out that first-line anti-tuberculosis therapy (ATT) may worsen ovarian damage by causing mitochondrial dysfunction in oocytes. For treatment, we propose the TB-FertiScore to assist personalized management: patients with a high risk (score ≥7) and severe tubo-ovarian damage should receive ATT combined with IVF, while those with less severe disease might benefit from ovulation induction along with intrauterine VEGF treatment. This comprehensive approach allows for precise, risk-based fertility preservation in areas heavily affected by the disease.

Section snippetsBackground

The impact of tuberculosis (TB) on women's reproductive health is particularly pronounced, with female genital tuberculosis (FGTB) accounting for 5 %–10 % of infertility cases in endemic regions (WHO, 2024, Bagchi et al., 2019). Approximately 25 %–30 % of extrapulmonary TB cases involve the genital tract (Silveira-Mattos et al., 2020), often presenting as latent or mildly symptomatic infections that may nonetheless lead to irreversible tissue damage (Gerald et al., 2010). Despite treatment with

Pathogenic mechanism linking TB and female infertility (Table 1, Fig. 1A-B)

Table 1, Table 2, Table 3, Table 4Genital tuberculosis (GTB) is one of the common types of extrapulmonary tuberculosis (EPTB), which mostly affects young adults. Due to the variation in clinical presentations (including asymptomatic infertility, atypical pelvic pain, and menstrual irregularities), lack of clear diagnostic procedures, slow detection speed, and low detection rates with traditional methods (encompassing acid-fast bacilli (AFB) smear, histopathology, and Lowenstein-Jensen culture),

Genomics in the elucidation of pathological processes (Fig. 2 A)

Genomics, defined as the study of an organism’s complete genome, has evolved from mere association analyses to providing molecular mechanisms underlying the pathogenesis of FGTB and associated infertility. By identifying key genetic variants regulating innate and adaptive immunity, genomics has elucidated the molecular basis of disease susceptibility and progression, thereby revealing potential host-directed therapeutic targets (Abdellaoui et al., 2023, Liu et al., 2016). Genomic analyses have

Drug reproductive toxicology reveals ATT damage to germ cells (Fig. 1 C, Table 3)

The use of anti-tuberculosis drugs may cause damage to reproductive cells (Rao et al., 2020, Akhigbe et al., 2021). The quantity and quality of oocytes are considered important factors that affect the outcome of assisted reproductive technologies. Studies have shown a significant association between tuberculosis infection and oocytes, suggesting that it may affect the outcome of assisted reproduction (Jirge et al., 2018, Sharma et al., 2018). Compared with the control group, patients in the

Clinical translation and challenges (Table 4)

FGTB-induced infertility represents a hidden epidemic of immunological origin, and multi-omics-guided fertility-sparing immunotherapies could alleviate disparities in high-TB-burden regions. Multi-omics techniques hold great potential for the early diagnosis of diseases, including tuberculosis. By integrating genomic, transcriptomic, proteomic, and metabolomic immune-omics data, it is possible to identify biomarkers that are specific to the early stages of the disease. These biomarkers can be

The efficacy of early diagnosis and treatment in preventing FGTB

The damage caused by FGTB to fertility is largely irreversible, making prevention far more effective than treating subsequent sequelae (Sharma et al., 2020). Early diagnosis and timely treatment of active pulmonary or EPTB constitute the cornerstone for preventing FGTB and its consequent lifelong infertility.

Interrupting hematogenous dissemination: FGTB typically originates from tuberculous foci in other parts of the body—most commonly the lungs—and spreads hematogenously to reproductive organs

The management of FGTB

The management of FGTB is a prolonged and challenging process, with objectives extending far beyond mere microbiological cure (Sharma et al., 2020). Conceptually, this process can be divided into two consecutive and distinct phases: (WHO, 2024) clearance of active infection, and (Bagchi et al., 2019) management of sequelae and restoration of fertility (Sharma, 2015).

Conclusions

FGTB is a major cause of irreversible infertility in endemic regions. This review synthesizes existing evidence, identifying immune-metabolic dysfunction as the core pathophysiological mechanism underlying FGTB-related infertility. We delineate a convergent pathogenic cascade: genetic susceptibility (e.g., TLR8 and VDR single nucleotide polymorphisms) triggers chronic inflammation and metabolic reprogramming, directly impairing endometrial receptivity (via suppression of LIF/VEGF/STAT3

Ethics approval and consent to participate

Not applicable.

Funding

Supported by the Key Research and Development program of Ningxia (2022CMG02028), the Central Guidance for Local Science and Technology Development (2024FRD05140), and the Sichuan Provincial Natural Science Foundation Project (2024NSFSC1675) for data fee (scientific research informed consent), paper modification, and publication fee.

CRediT authorship contribution statement

Rong Hu: Writing – review & editing, Visualization, Supervision, Funding acquisition, Conceptualization. Linlin Song: Supervision, Investigation. Yunxing Fu: Project administration, Funding acquisition, Conceptualization. Guiyi Ji: Writing – review & editing, Writing – original draft, Visualization, Supervision, Project administration, Methodology, Investigation, Conceptualization.

Declaration of Competing Interest

The authors declare no conflict of interest.

Acknowledgments

Not applicable.

Consent for publication

Not applicable.

Authors’ Contributions

All authors have approved the manuscript that is enclosed. G.J. and Y.F. contributed equally to this work. The authors’ contributions are detailed: Conceptualization: G.J. and R.H.; Methodology: Y.F.; Formal analysis and investigation: L.S.; Writing - original draft preparation: G.J.; Writing - review and editing: Y.F.; Funding acquisition: R.H.; Resources: R.H.; Supervision: R.H.

References (97)Z. Liu et al.Potential reuse of oncology drugs in the treatment of rare diseases

Trends Pharmacol. Sci.

(2016)

F. Liu et al.Acetylome analysis reveals diverse functions of lysine acetylation in Mycobacterium tuberculosis

Mol. Cell Proteom.

(2014)

N. Malhotra et al.The effect of tuberculosis on ovarian reserve among women undergoing IVF in India

Int. J. Gynaecol. Obstet.

(2012)

P. Qiao et al.Oral isoniazid causes oxidative stress, oocyte deterioration and infertility in mice

Toxicology

(2021)

A. Rao et al.Ethambutol induces testicular damage and decreases the sperm functional competence in Swiss albino mice

Environ. Toxicol. Pharmacol.

(2016)

A. Rao et al.Exposure to first line anti-tuberculosis drugs in prepubertal age reduces the quality and functional competence of spermatozoa and oocytes in Swiss albino mice

Environ. Toxicol. Pharmacol.

(2020)

J.B. Sharma et al.Evaluation of Gene Xpert as compared to conventional methods in diagnosis of female genital tuberculosis

Eur. J. Obstet. Gynecol. Reprod. Biol.

(2020)

M. Agarwal et al.Adjunctive intravitreal anti-vascular endothelial growth factor and moxifloxacin therapy in management of intraocular tubercular granulomas

Ocul. Immunol. Inflamm.

(2021)

R.E. Akhigbe et al.Co-administration of HAART and antikoch triggers cardiometabolic dysfunction through an oxidative stress-mediated pathway

Lipids Health Dis.

(2021)

A.A. Al eryani et al.Genital tuberculosis is common among females with tubal factor infertility: observational study

Alex. J. Med.

(2019)

A.S. de Almeida et al.Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis

Clin. Vaccin. Immunol.

(2012)

B. Bagchi et al.Role of latent female genital tuberculosis in recurrent early pregnancy loss: a retrospective analysis

Int. J. Reprod. Biomed.

(2019)

P. Banerjee et al.1)H NMR serum metabonomics for understanding metabolic dysregulation in women with idiopathic recurrent spontaneous miscarriage during implantation window

J. Proteome Res.

(2014)

P. Birari et al.Nur77 influences immunometabolism to regulate the release of proinflammatory cytokines and the formation of lipid bodies during Mycobacterium tuberculosis infection of macrophages

Pathog. Dis.

(2023)

B. Bongiovanni et al.The IMmunoregulatory Actions of DHEA in tuberculosis, A tool for therapeutic intervention?

Front. Endocrinol.

(2022)

R. Bujak et al.Metabolomics reveals metabolite changes in acute pulmonary embolism

J. Proteome Res.

(2014)

E. Caliskan et al.Effects of salpingectomy and antituberculosis treatments on fertility results in patients with genital tuberculosis

J. Obstet. Gynaecol. Res.

(2014)

S. Cao et al.Vitamin D receptor genetic polymorphisms and tuberculosis among Chinese Han ethnic group

Chin. Med. J.

(2012)

B.G. CasslenFree amino acids in human uterine fluid. Possible role of high taurine concentration

J. Reprod. Med.

(1987)

S. Chatterjee et al.Role of endometrial cytokines of the female genital tract tuberculosis in the context of infertility

BLDE Univ. J. Health Sci.

(2018)

J.G. Cheng et al.Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation

Proc. Natl. Acad. Sci. USA

(2001)

B. Cogliati et al.Friend or foe? The elusive role of hepatic stellate cells in liver cancer

Nat. Rev. Gastroenterol. Hepatol.

(2023)

W. Dai et al.In vitro fertilization outcome in women with endometrial tuberculosis and tubal tuberculosis

Gynecol. Endocrinol.

(2020)

P. Dam et al.Role of latent genital tuberculosis in repeated IVF failure in the Indian clinical setting

Gynecol. Obstet. Investig.

(2006)

M.J. Dickson et al.Experimentally induced endometritis impairs the developmental capacity of bovine oocytes

Dagger Biol. Reprod.

(2020)

M. Eftekhar et al.Mycobacterium tuberculosis infection in women with unexplained infertility

Int. J. Reprod. Biomed.

(2015)

Y. Gan et al.Estradiol inhibits autophagy of Mycobacterium tuberculosisinfected 16HBE cells and controls the proliferation of intracellular Mycobacterium tuberculosis

Mol. Med. Rep.

(2022)

H. Gerald et al.Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010

MMWR Pract. Guidel.

(2010)

S. Gupta et al.Etiopathogenesis, challenges and remedies associated with female genital tuberculosis: potential role of nuclear receptors

Front. Immunol.

(2020)

E. HambartsoumianEndometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation

Am. J. Reprod. Immunol.

(1998)

T. Hasan et al.Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines

BMJ Open

(2018)

M. Ishida et al.Induction of the epithelial-mesenchymal transition in the endometrium by chronic endometritis in infertile patients

PLOS One

(2021)

Q. Jiang et al.Glutamine is required for M1-like polarization of macrophages in response to mycobacterium tuberculosis infection

mBio

(2022)

U.N. Jindal et al.Favorable infertility outcomes following anti-tubercular treatment prescribed on the sole basis of a positive polymerase chain reaction test for endometrial tuberculosis

Hum. Reprod.

(2012)

P.R. Jirge et al.Latent genital tuberculosis adversely affects the ovarian reserve in infertile women

Hum. Reprod.

(2018)

J. Kitazawa et al.Alteration in endometrial helper T-cell subgroups in chronic endometritis

Am. J. Reprod. Immunol.

(2021)

A. Kumar et al.Antigonadotrophic effect of mycobacterium tuberculosis

Horm. Metab. Res

(1997)

C.J. Li et al.Dehydroepiandrosterone shifts energy metabolism to increase mitochondrial biogenesis in female fertility with advancing age

Nutrients

(2021)

View full text

© 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Comments (0)

No login
gif